Uncategorized

As part of the coordinated management of the litigation, the parties are currently engaged in a discovery process that will […]

For all the consumer-facing headlines of generative AI’s healthcare failures—some less serious, others more troubling—a contrast is unfolding in the greater

Suboxone (buprenorphine and naloxone) was approved by the FDA in 2002, for treatment of recovering opioid addicts, helping them avoid

Pharmaceutical Marketing Evolved Transform your DTC marketing with AI-powered precision targeting. Drive better patient outcomes and commercial success through privacy-safe

Founded in 1968 by Edward M. Swartz, W.A.T.C.H. is a non-profit organization that is dedicated to raising awareness about the

Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. In a recent interview, Arun Menawat, CEO

In 2020, the FDA determined that a “Black Box” label warning about risk of suicide on Singular was necessary. In

Not long after the litigation was established, the court approved a Hair Relaxer Lawsuit Master Long-Form Complaint, which has allowed

Stryker quietly removed Cartiva from the market and called for medical providers to return all existing devices, after acknowledging that

Building a “Best Practice” R&D Organization in Biopharma We interviewed 14 R&D biopharma leaders on the critical success factors for